NDC 64764-300 – Entyvio
Vedolizumab 300 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC64764-300
Product details
- Brand name
- Entyvio
- Generic name
- vedolizumab
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA125476
- Marketed since
- May 20, 2014
- Listing expires
- December 31, 2027
- Pharmacologic class
- Integrin Receptor Antagonist
Active ingredients
- Vedolizumab 300 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 64764-300-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE | May 20, 2014 |
Other Entyvio products
- 64764-107 Vedolizumab 108 mg/.68mL · Injection, Solution · Takeda Pharmaceuticals America, Inc.